Noticias de Eulerpool Aptose Biosciences

Aptose Biosciences Noticias de Acciones

Aptose Biosciences es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Aptose Biosciences.

• 1 de julio ·

  Yahoo
  Aptose Upgraded to Trade on OTCQB Market
• 20 de junio ·

  Yahoo
  Aptose and Hanmi Enter New Loan Agreement to Advance Development of Tuspetinib in Triplet Therapy for AML
• 17 de junio ·

  Yahoo
  Aptose Provides Corporate Updates
• 12 de junio ·

  Yahoo
  Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2025 EHA Congress
• 27 de mayo ·

  Yahoo
  Aptose Announces Results from Annual and Special Meeting of Shareholders
• 23 de abril ·

  Yahoo
  Aptose Announces Auditor Not Standing for Re-Appointment
• 29 de marzo ·

  Yahoo
  Aptose Biosciences price target raised to $6 from $2 at H.C. Wainwright
• 17 de marzo ·

  Yahoo
  Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliance
• 12 de febrero ·

  Yahoo
  Sector Update: Health Care Stocks Retreat Late Afternoon
• 9 de enero ·

  Yahoo
  Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial